Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality

Cancer

Volumn 120, Issue 18, 2014, Pages 2910-2918

  Psutka, Sarah P ^a   Carrasco, Alonso ^a   Schmit, Grant D ^b   Moynagh, Michael R ^b   Boorjian, Stephen A ^a   Frank, Igor ^a   Stewart, Suzanne B ^a   Thapa, Prabin ^b   Tarrell, Robert F ^b   Cheville, John C ^b   Tollefson, Matthew K ^a  

^a DEPARTMENT OF UROLOGY   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Bladder cancer; Frailty; Mortality; Radical cystectomy; Sarcopenia; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; CYSTECTOMY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; SARCOPENIA; SKELETAL MUSCLE; SURVIVAL RATE; SURVIVAL TIME; TRANSITIONAL CELL CARCINOMA; BLADDER CANCER; BLADDER TUMOR; CAUSE OF DEATH; COHORT ANALYSIS; COMPARATIVE STUDY; FRAILTY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL;

BLADDER CANCER; FRAILTY; MORTALITY; RADICAL CYSTECTOMY; SARCOPENIA; SURVIVAL;

AGED; CAUSE OF DEATH; COHORT STUDIES; CYSTECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SARCOPENIA; SURVIVAL RATE; URINARY BLADDER NEOPLASMS;

EID: 84908028657     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28798     Document Type: Article

References (36)

1. American Cancer Society. Cancer Facts & Figures 2013. Atlanta, GA: American Cancer Society; 2013. cancer.org/research/cancerfacts-figures/cancerfactsfigures/cancer-facts-figures-2013. Accessed February 25, 2014.
2. Prout GR Jr, Wesley MN, Yancik R, Ries LA, Havlik RJ, Edwards BK. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer. 2005;104: 1638-1647.
3. Aziz A, May M, Burger M, et al; PROMETRICS 2011 Research Group. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort [published online ahead of print December 27, 2013]. Eur Urol. doi: 10.1016/j.eururo. 2013.12.018.
4. Kluth LA, Rieken M, Xylinas E, et al. Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients [published online ahead of print December 5, 2013]. Eur Urol. 2013. doi: 10.1016/j.eururo. 2013.11.040.
5. Ploussard G, Shariat SF, Dragomir A, et al. Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time [published online ahead of print October 9, 2013]. Eur Urol. 2013. doi: 10.1016/j.eururo. 2013.09.050.
6. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res. 2006;12:6663-6676.
7. Boorjian SA, Kim SP, Tollefson MK, et al. Comparative performance of comorbidity indices for estimating perioperative and 5-year all-cause mortality following radical cystectomy for bladder cancer. J Urol. 2013;190:55-60.
8. Eisenberg MS, Boorjian SA, Cheville JC, et al. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer. J Urol. 2013;190:2005-2010.
9. Peng P, Hyder O, Firoozmand A, et al. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gas-trointest Surg. 2012;16:1478-1486.
10. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med. 1980;69:491-497.
11. Mourtzakis M, Prado CM, Lieffers JR, Reiman T, McCargar LJ, Baracos VE. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008; 33:997-1006.
12. Mir O, Coriat R, Blanchet B, et al. Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma. PLoS One. 2012;7:e37563.
13. Del Fabbro E, Parsons H, Warneke CL, et al. The relationship between body composition and response to neoadjuvant chemotherapy in women with operable breast cancer. Oncologist. 2012;17: 1240-1245.
14. Martin L, Birdsell L, Macdonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539-1547.
15. Baracos V, Kazemi-Bajestani SM. Clinical outcomes related to muscle mass in humans with cancer and catabolic illnesses. Int J Biochem Cell Biol. 2013;45:2302-2308.
16. Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarco-penia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol. 2011;18:3579-3585.
17. Antoun S, Borget I, Lanoy E. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. Curr Opin Support Palliat Care. 2013;7:383-389.
18. Demark-Wahnefried W, Kenyon AJ, Eberle P, Skye A, Kraus WE. Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study. Clin Exerc Physiol. 2002;4:44-49.
19. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011; 12:489-495.
20. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, Lyons W, Gallagher D, Ross R. Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol (1985). 1998;85:115-122.
21. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
22. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004;18:39-51.
23. Waters DL, Baumgartner RN, Garry PJ, Vellas B. Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging. 2010;5:259-270.
24. Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg. 2013;100:1523-1530.
25. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res. 2009;15:6973-6979.
26. Smith AB, Deal AM, Yu H, et al. Sarcopenia as a predictor for complications and survival following radical cystectomy [published online ahead of print January 11, 2014]. J Urol. doi: 10.1016/j.juro. 2013.12.047.
27. Wan F, Zhu Y, Gu C, et al. Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer. World J Surg Oncol. 2014;12:14.
28. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg. 2012;99: 550-557.
29. Revenig LM, Canter DJ, Taylor MD, et al. Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes. J Am Coll Surg. 2013;217:665-670.e1.
30. Reisinger KW, van Vugt JL, Tegels JJ, et al. Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery [published online ahead of print March 19, 2014]. Ann Surg.
31. Landi F, Marzetti E, Martone AM, Bernabei R, Onder G. Exercise as a remedy for sarcopenia. Curr Opin Clin Nutr Metab Care. 2014; 17:25-31.
32. Robinson S, Cooper C, Aihie Sayer A. Nutrition and sarcopenia: a review of the evidence and implications for preventive strategies. J Aging Res. 2012;2012:510801.
33. Orr R, Fiatarone Singh M. The anabolic androgenic steroid oxan-drolone in the treatment of wasting and catabolic disorders: review of efficacy and safety. Drugs. 2004;64:725-750.
34. Cooper C, Dere W, Evans W, et al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int. 2012;23:1839-1848.
35. Morgan TM, Tang D, Stratton KL, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol. 2011;59:923-928.
36. Morgan TM, Keegan KA, Barocas DA, et al. Predicting the probability of 90-day survival of elderly patients with bladder cancer treated with radical cystectomy. J Urol. 2011;186:829-834.